Melanoma and microbiota: Current understanding and future directions.

Autor: Routy B; University of Montreal Research Center (CRCHUM), Montreal, QC H2X 0A9, Canada; Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC H2X 3E4, Canada., Jackson T; Melanoma Research Alliance, 730 15th Street NW, Washington, DC 20005, USA., Mählmann L; Seerave Foundation, The Seerave Foundation, 35-37 New Street, St Helier, JE2 3RA Jersey, UK., Baumgartner CK; Oncology Discovery Research, AbbVie Inc, North Chicago, IL 60064, USA., Blaser M; Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, NJ 08854, USA., Byrd A; Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080, USA., Corvaia N; MaaT Pharma, 69007 Lyon, France., Couts K; Department of Medicine, Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA., Davar D; Department of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, USA., Derosa L; Gustave Roussy Cancer Center, ClinicoBiome, 94805 Villejuif, France; Université Paris Saclay, Faculty of Medicine, 94270 Kremlin Bicêtre, France; Inserm U1015, Equipe Labellisée par la Ligue Contre le Cancer, 94800 Villejuif, France., Hang HC; Departments of Immunology & Microbiology and Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA., Hospers G; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ, Groningen, The Netherlands., Isaksen M; Bio-Me, 0349 Oslo, Norway., Kroemer G; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, 75006 Paris, France; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94905 Villejuif, France; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, 75015 Paris, France., Malard F; Sorbonne Université, Centre de Recherche Saint-Antoine INSERM UMRs938, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France., McCoy KD; Department of Physiology & Pharmacology, Snyder Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada., Meisel M; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA USA; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA USA., Pal S; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA., Ronai Z; Sanford Burnham Prebys Discovery Medical Research Institute, La Jolla, CA 92037, USA., Segal E; Weizmann Institute of Science, Computer Science and Applied Mathematics Department, 234th Herzel st., Rehovot 7610001, Israel., Sepich-Poore GD; Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA; Micronoma Inc., San Diego, CA 92121, USA., Shaikh F; Johns Hopkins School of Medicine, Department of Oncology, Baltimore, MD 21287, USA., Sweis RF; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA., Trinchieri G; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., van den Brink M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Immunology, Sloan Kettering Institute, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA., Weersma RK; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Whiteson K; Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA 92697, USA., Zhao L; Department of Biochemistry and Microbiology, New Jersey Institute of Food, Nutrition and Health, Rutgers University, New Brunswick, NY 08901, USA., McQuade J; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: jmcquade@mdanderson.org., Zarour H; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA. Electronic address: zarourhm@upmc.edu., Zitvogel L; Gustave Roussy Cancer Center, ClinicoBiome, 94805 Villejuif, France; Université Paris Saclay, Faculty of Medicine, 94270 Kremlin Bicêtre, France; Inserm U1015, Equipe Labellisée par la Ligue Contre le Cancer, 94800 Villejuif, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Gustave Roussy, 94805 Villejuif, France. Electronic address: laurence.zitvogel@orange.fr.

Publikováno v: Cancer cell [Cancer Cell] 2024 Jan 08; Vol. 42 (1), pp. 16-34. Date of Electronic Publication: 2023 Dec 28.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Severe combined immunodeficiency disease

Autor: Militsakh, O., Day, T., Hornig, J., Lentsch, E., Skoner, J., Gillespie, M., Sharma, A., Neville, B., Rumboldt, Z., James, R., Goddard, J., Shikata, K., Doi, Y., Rosen, E. M., Goldberg, I. D., Fan, S., Kong, L., Lu, J. J., Chlenski, A., Cohn, S. L., Hlubek, F., Qian, C.-N., Teh, B. T., Batistatou, A., Charalbopoulos, K., Christensen, C., Reddel, R., Ploeg, I. M. C., Kroon, B. B. R., Nieweg, O. E., Rijk, M. C., Winqvist, O., Thorn, M., Zwick, C., Pfreundschuh, M., Knudsen, B. S., Lucas, J., Nelson, P., Kashikar, N., Datta, P. K., Hottinger, A. F., Hormigo, A., Knobler, E., Knobler, R., McCarty, J. H., Bardia, A., Loprinzi, C., Buettner, R., Jove, R., Garcia, R., Frank, D. A., Nakatsura, T., Witt, O., Yoshida, K., Chou, P.-L., Tsay, G. J., Takeuchi, T., Furihata, M., Robertson, F. M., Werbowetski-Ogilvie, T. E., Maestro, R. F., Sadr, M. S., Dennler, S., Dijke, P., Gadgeel, S., Tierauch, K.-H., Yip, K. W., Liu, F.-F., Cano, A., Neto, M. A., Rünger, T. M., Frühwald, Michael C., Trakhtenbrot, L., Mi, J., Larner, J. M., Hamlin, J. L., Radin, N. S., Lo, T. L., Guy, G. R., Yeudall, W. A., Parsons, S. J., Fan, F., Platanias, L. C., Mcgahren-Murray, M., Keyomarsi, K., Kos, J., Seigel, G. M., Alison, M. R., Hiyama, E., Renehan, A. G., Potten, C. S., Tang, D. G., Foster, P., Lin, K., Bergelt, C., Ronai, Z., Cukierman, E., Aumercier, M., Hodson, M., Lolis, E., Mehta, A., Chung, F.-L., Glatt, H., Oberthür, A., Warnat, P., Aranda, S., Culig, Z., Chung, B. H., Shin, Y.-B., Kim, M., Grevenstein, W. M. U., van Eijck, C. H. J., Baker, S. G., Kramer, B. S., Mahotka, C., Carbone, M., Yang, H., Mueller, S. C., Coopman, P. J., Brujin, D., Kessel, A. D., George, J. M.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3341::a44e8bd08702a716a484e81f216ca121
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/73530

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome.

Autor: Dinstag G; Pangea Biomed Ltd., Tel Aviv, Israel. Electronic address: gal@pangeabiomed.com., Shulman ED; Pangea Biomed Ltd., Tel Aviv, Israel., Elis E; Pangea Biomed Ltd., Tel Aviv, Israel., Ben-Zvi DS; Pangea Biomed Ltd., Tel Aviv, Israel., Tirosh O; Pangea Biomed Ltd., Tel Aviv, Israel., Maimon E; Pangea Biomed Ltd., Tel Aviv, Israel., Meilijson I; Pangea Biomed Ltd., Tel Aviv, Israel; Tel Aviv University, Tel Aviv, Israel., Elalouf E; Pangea Biomed Ltd., Tel Aviv, Israel., Temkin B; Pangea Biomed Ltd., Tel Aviv, Israel., Vitkovsky P; Pangea Biomed Ltd., Tel Aviv, Israel., Schiff E; Pangea Biomed Ltd., Tel Aviv, Israel., Hoang DT; Biological Data Science Institute, College of Science, The Australian National University, Canberra, ACT, Australia., Sinha S; Cancer Data Science Laboratory (CDSL), National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Nair NU; Cancer Data Science Laboratory (CDSL), National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lee JS; Department of Precision Medicine, School of Medicine & Department of Artificial Intelligence, Sungkyunkwan University, Suwon, Republic of Korea., Schäffer AA; Cancer Data Science Laboratory (CDSL), National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Ronai Z; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA., Juric D; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA., Apolo AB; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Dahut WL; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lipkowitz S; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Berger R; Cancer Center, Chaim Sheba Medical Center, Tel Hashomer, Israel., Kurzrock R; Worldwide Innovative Network (WIN) for Personalized Cancer Therapy, Chevilly-Larue, France., Papanicolau-Sengos A; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Karzai F; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Aldape K; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Rajagopal PS; Cancer Data Science Laboratory (CDSL), National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Beker T; Pangea Biomed Ltd., Tel Aviv, Israel. Electronic address: tuvik@pangeabiomed.com., Ruppin E; Cancer Data Science Laboratory (CDSL), National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: eytan.ruppin@nih.gov., Aharonov R; Pangea Biomed Ltd., Tel Aviv, Israel. Electronic address: ranit@pangeabiomed.com.

Publikováno v: Med (New York, N.Y.) [Med] 2023 Jan 13; Vol. 4 (1), pp. 15-30.e8. Date of Electronic Publication: 2022 Dec 12.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.